Kulina E.V.
Role of omega-3 unsaturated fatty acids in treatment of progressive kidney diseases
|
№6 / 2011
|
V.V. Fomin. L.V. Kozlovskaya, Yu.S. Milovanov
Cardiomyopathy in anemia, associated with chronic kidney disease: role of erythropoetin-beta
|
№6 / 2011
|
A.P. Rebrov, E.V. Voloshinova, M.A. Tiapkina
Prevalence of chronic kidney disease and it’s etiological structure in patients with rheumatoid arthritis
|
№6 / 2011
|
Jh.D. Koblava, M.A. Efremovtseva, S.V. Villevalde
Cardio-renal syndromes
|
№6 / 2011
|
L.V. Kozlovskaya, Yu.S. Milovanova, L.Yu. Milovanova
Optimal target hemoglobin level in chronic kidney disease patients, treated with erythropoesis-stimulating agents: controversial questions
|
№5 / 2011
|
V.V. Fomin, L.V. Kozlovskaya, Yu.S. Milovanov, L.Yu. Milovanova
Cardio-renal anemia syndrome: correction with iron sucrose
|
№4 / 2011
|
G.A. Makovetskaya, S.S. Terehin, Z.B. Danilova, Yu.Yu. Bazranova, I.V. Barinov
Interdisciplinary approach to management of children with obstructive nephropathy in prevention of chronic kidney disease
|
№4 / 2011
|
M.S. Molchanova, E.K. Petrosian, T.E. Pankratenko, D.V. Zverev, A.L. Rumiantsev, L.P. Bykova, L.A. Gracheva
Use of cinacalcet in children with chronic kidney disease stage V
|
№4 / 2011
|
M.S. Molchanova, E.K. Petrosian, S.E. Kazymova, E.A. Molchanova
Growth retardation and body mass deficiency in children with chronic kidney disease stage II – V (Russian registry of children with chronic renal failure)
|
№4 / 2011
|
N.S. Kirshina, L.T. Pimenov
Chronic kidney disease risk factors in development of renal dysfunction in chronic heart failure patients
|
№3 / 2011
|
M.V. Avdeeva, L.V. Scheglova
Opportunities of healthcare centers in detection of patients with kidney disease and cardiovascular risk
|
№3 / 2011
|
Yu.S. Miluvanova, L.Yu. Milovanova, L.V. Kozlovskaya
Variants of renal osteodystrophy
|
№3 / 2011
|